Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
Population
1 participant in the RE-LY trial on dabigatran who unintentionally underwent cardiac surgery and experienced…
Design
Case_report
Authors
Discussion
Loading...
Member takes
Implication
May support rFVIIa plus hemodialysis for refractory dabigatran bleeding post-surgery; hypothesis-generating and should not change practice.
Structured PICO
P
Population
1 participant in the RE-LY trial on dabigatran who unintentionally underwent cardiac surgery and experienced massive bleeding
I
Intervention
Recombinant factor VIIa (rFVIIa) and hemodialysis
This case report discusses the use of recombinant factor VIIa and hemodialysis for managing massive dabigatran-associated bleeding after cardiac surgery.
Cite This Study
Warkentin et al. (2012) studied this question.